SPMC

Select a document to view

RINVOQ® INN-Upadacitinib
RINVOQ® 15 mg
RINVOQ® 30 mg
Our therapy areas
Oncology
Immunology
Medical Information
 
Additional info
Privacy Notice
Terms Of Use

This website is intended for Gulf Healthcare Professionals

AbbVie Biopharmaceuticals GmbH.

 

Suite 2901, U Bora Tower,Business Bay, Dubai, UAE

PO Box:: 118052

OFFICE : +971 4 5506100

FAX: +971 4 5506101

Your safety is our priority, we will remain always by your side; if you have any safety complaint, please contact us on:

PV.MEA@Abbvie.com or Hotline: +971564135746/+96522052024

For product quality complaints: 

Email: eemea-pharmapqc@abbvie.com

 

To report any side effects, please contact AbbVie Biopharmaceuticals GmbH via:

Email:  PV.GLV@abbvie.com

Hotline: +971-588 154 578/ +965-22-052 024/ +961-70-122 946

 

For product quality complaints: 

Email: eemea-pharmapqc@moh.gov.om

 

For Oman's HCPs.

Department of Pharmacovigilance

Drug Safety Center

Ministry of Health, Sultanate of Oman

Phone Nos: :00968 22357660/00968 22357686/

                       00968 22357626/00968 22358900

Email: Pharma-vigil@moh.gov.om

Website: www.moh.gov.om